A Role of Indacaterol in Chronic Obstructive Pulmonary Disease Management: a Turning Point or Crossroads?

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2013 Aug 31

PMID 23991289

Authors

Gregory J Feldman

Anton Edin

Affiliations

Soon will be listed here.

References

Feldman G . Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol. Int J Chron Obstruct Pulmon Dis. 2013; 8:89-96. PMC: 3575129. DOI: 10.2147/COPD.S31209. View

Barnes P . Glucocorticosteroids: current and future directions. Br J Pharmacol. 2011; 163(1):29-43. PMC: 3085866. DOI: 10.1111/j.1476-5381.2010.01199.x. View

Decramer M, Dahl R, Kornmann O, Korn S, Lawrence D, McBryan D . Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use. Respir Med. 2012; 107(2):223-32. DOI: 10.1016/j.rmed.2012.10.022. View

Han M, Postma D, Mannino D, Giardino N, Buist S, Curtis J . Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007; 176(12):1179-84. PMC: 2720110. DOI: 10.1164/rccm.200704-553CC. View

Bleecker E, Siler T, Owen R, Kramer B . Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data. Int J Chron Obstruct Pulmon Dis. 2011; 6:431-8. PMC: 3186741. DOI: 10.2147/COPD.S21073. View

Fishman A . One hundred years of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005; 171(9):941-8. DOI: 10.1164/rccm.200412-1685OC. View

Ribeiro M, Chapman K . Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2012; 7:145-52. PMC: 3299544. DOI: 10.2147/COPD.S19805. View

Rodrigo G, Neffen H . Comparison of indacaterol with tiotropium or twice-daily long-acting β -agonists for stable COPD: a systematic review. Chest. 2012; 142(5):1104-1110. DOI: 10.1378/chest.11-2252. View

Mathers C, Loncar D . Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11):e442. PMC: 1664601. DOI: 10.1371/journal.pmed.0030442. View

10.

Bateman E, Ferguson G, Barnes N, Gallagher N, Green Y, Henley M . Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J. 2013; 42(6):1484-94. PMC: 3844137. DOI: 10.1183/09031936.00200212. View

11.

Kruis A, van Adrichem J, Erkelens M, Scheepers H, Veen H, Muris J . Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients. Int J Chron Obstruct Pulmon Dis. 2010; 5:407-13. PMC: 3008326. DOI: 10.2147/COPD.S9654. View

12.

Mahler D, DUrzo A, Bateman E, Ozkan S, White T, Peckitt C . Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison. Thorax. 2012; 67(9):781-8. DOI: 10.1136/thoraxjnl-2011-201140. View

13.

Lopez-Campos J, Calero C, Quintana-Gallego E . Symptom variability in COPD: a narrative review. Int J Chron Obstruct Pulmon Dis. 2013; 8:231-8. PMC: 3653762. DOI: 10.2147/COPD.S42866. View

14.

Mapel D, Dalal A, Blanchette C, Petersen H, Ferguson G . Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis. 2011; 6:573-81. PMC: 3224652. DOI: 10.2147/COPD.S16975. View

15.

Yawn B, Li Y, Tian H, Zhang J, Arcona S, Kahler K . Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis. Int J Chron Obstruct Pulmon Dis. 2013; 8:295-304. PMC: 3699136. DOI: 10.2147/COPD.S42366. View

16.

Agusti A, Calverley P, Celli B, Coxson H, Edwards L, Lomas D . Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010; 11:122. PMC: 2944278. DOI: 10.1186/1465-9921-11-122. View

17.

Beier J, Beeh K . Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol. Int J Chron Obstruct Pulmon Dis. 2011; 6:237-43. PMC: 3144843. DOI: 10.2147/COPD.S7371. View